Cargando…
Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal Cancer Treatment
Immunotoxins (ITXs) are chimeric molecules that combine the specificity of a targeting domain, usually derived from an antibody, and the cytotoxic potency of a toxin, leading to the selective death of tumor cells. However, several issues must be addressed and optimized in order to use ITXs as therap...
Autores principales: | Narbona, Javier, Hernández-Baraza, Luisa, Gordo, Rubén G., Sanz, Laura, Lacadena, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377705/ https://www.ncbi.nlm.nih.gov/pubmed/37509078 http://dx.doi.org/10.3390/biom13071042 |
Ejemplares similares
-
A New Optimized Version of a Colorectal Cancer-Targeted Immunotoxin Based on a Non-Immunogenic Variant of the Ribotoxin α-Sarcin
por: Narbona, Javier, et al.
Publicado: (2023) -
Antibody-Based Immunotoxins for Colorectal Cancer Therapy
por: Sanz, Laura, et al.
Publicado: (2021) -
Inclusion of a Furin Cleavage Site Enhances Antitumor Efficacy against Colorectal Cancer Cells of Ribotoxin α-Sarcin- or RNase T1-Based Immunotoxins
por: Ruiz-de-la-Herrán, Javier, et al.
Publicado: (2019) -
Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro
por: Deng, Cuimin, et al.
Publicado: (2017) -
Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin α-sarcin in nude mice bearing human colorectal cancer xenografts
por: Tomé-Amat, Jaime, et al.
Publicado: (2015)